Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study

被引：0
|
作者：
Min Zheng
Xiang Chen
Feng Wang
Jisu Chen
Kimberley Jackson
Fan Yang
Christopher Payne
HongYing Li
YiHui Wang
ZiPei Xiao
Jie Zheng
机构：
[1] The Second Affiliated Hospital,Department of Dermatology
[2] Zhejiang University School of Medicine,Department of Dermatology
[3] Xiangya Hospital,Department of Dermatology, School of Medicine
[4] Central South University,undefined
[5] Lilly Suzhou Pharmaceutical Co. Ltd,undefined
[6] Eli Lilly and Company,undefined
[7] Eli Lilly and Company,undefined
[8] Rui Jin Hospital,undefined
[9] Shanghai Jiao Tong University,undefined
来源：
Advances in Therapy | 2023年 / 40卷
关键词：
Psoriasis; Interleukin-17A; Phase 1; Pharmacokinetics; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3804 / 3816
页数：12
相关论文
共 50 条
  • [1] Pharmacokinetics, Safety, and Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Plaque Psoriasis: A Phase 1, Single- and Multiple-Dose Study
    Zheng, Min
    Chen, Xiang
    Wang, Feng
    Chen, Jisu
    Jackson, Kimberley
    Yang, Fan
    Payne, Christopher
    Li, HongYing
    Wang, YiHui
    Xiao, ZiPei
    Zheng, Jie
    ADVANCES IN THERAPY, 2023, 40 (09) : 3804 - 3816
  • [2] Pharmacokinetics, safety and efficacy of ixekizumab in Chinese patients with plaque psoriasis: Results from a phase 1 single- and multiple-dose study
    Wang, Feng
    Zheng, Min
    Chen, Xiang
    Chen Jisu
    Jackson, Kimberley
    Yang, Fan Emily
    Payne, Christopher
    Zheng, Jie
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB129 - AB129
  • [3] Efficacy and Safety of Ixekizumab in Pediatric Patients with Moderate-to-Severe Plaque Psoriasis
    Paller, Amy
    Seyger, Marieke
    Alejandro Magarinos, Gabriel
    Bagel, Jerry
    Keller, Stuart
    Capriles, Claudia Rodriguez
    Gallo, Gaia
    Edson-Heredia, Emily
    Li, Lingnan
    Xu, Wen
    Papp, Kim
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 : 17 - 17
  • [4] Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
    Li Ying
    Ji Suyun
    Liang Yanhua
    Liang Yunsheng
    Deng Li
    Dang Lin
    Lv Chengzhi
    Lin Bingjiang
    Zhang Furen
    Shi Wendi
    Li Jinnan
    Dong Yu
    Dou Guanshen
    Yuling Shi
    Advances in Therapy, 2023, 40 : 5464 - 5474
  • [5] Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study
    Ying, Li
    Suyun, Ji
    Yanhua, Liang
    Yunsheng, Liang
    Li, Deng
    Lin, Dang
    Chengzhi, Lv
    Bingjiang, Lin
    Furen, Zhang
    Wendi, Shi
    Jinnan, Li
    Yu, Dong
    Guanshen, Dou
    Shi, Yuling
    ADVANCES IN THERAPY, 2023, 40 (12) : 5464 - 5474
  • [6] Efficacy and safety of ixekizumab in Chinese patients with moderate-to-severe plaque psoriasis: 12-week results from a phase 3 study
    Rui, Wenlong
    Li, Xia
    Zheng, Jie
    Pan, Weili
    Zheng, Min
    Lu, Yan
    Li, Fuqiu
    Ding, Yangfeng
    Zhang, Jianzhong
    Li, Hongying
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB55 - AB55
  • [7] Efficacy and Safety of Ixekizumab in Chinese Patients With Moderate-to-Severe Plaque Psoriasis: 60-Week Results From a Phase 3 Study
    Li Xia
    Zheng Jie
    Pan WeiLi
    Zheng Min
    Lu Yan
    Li FuQiu
    Ding YangFeng
    Zhang JianZhong
    Li HongYing
    Rui WenLong
    国际皮肤性病学杂志（英文）, 2022, 05 (04)
  • [8] Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and comorbid diabetes mellitus
    Egeberg, A.
    Schaekel, K.
    Puig, L.
    Saure, D.
    Yali Wang, I.
    Pavo, I.
    Mahar, P.
    Schuster, C.
    Griffiths, C. E. M.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (01) : E31 - E31
  • [9] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
    Gordon, K. B.
    Blauvelt, A.
    Papp, K. A.
    Langley, R. G.
    Luger, T.
    Ohtsuki, M.
    Reich, K.
    Amato, D.
    Ball, S. G.
    Braun, D. K.
    Cameron, G. S.
    Erickson, J.
    Konrad, R. J.
    Muram, T. M.
    Nickoloff, B. J.
    Osuntokun, O. O.
    Secrest, R. J.
    Zhao, F.
    Mallbris, L.
    Leonardi, C. L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 345 - 356
  • [10] Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
    Egeberg, Alexander
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (21): : 2101 - 2102
12345